What labs are needed to restart Pre-Exposure Prophylaxis (PrEP) after a 2-year hiatus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Testing for Restarting PrEP After 2-Year Hiatus

When restarting PrEP after a 2-year hiatus, you must obtain HIV testing (both a fourth- or fifth-generation laboratory-based antigen-antibody test AND an HIV RNA test with lower limit of quantification ≤50 copies/mL), serum creatinine with calculated creatinine clearance, hepatitis B surface antigen, and STI screening before reinitiating medication. 1

Mandatory HIV Testing Before Restart

The 2025 International Antiviral Society-USA guidelines are explicit that after a hiatus exceeding 14 days for tenofovir-based oral PrEP (or 6 months for long-acting cabotegravir), HIV screening should ideally include both an HIV RNA test and a laboratory-based antigen-antibody test before restarting. 1

  • HIV RNA (viral load) test with lower limit of quantification of 50 copies/mL or lower is the gold standard for detecting acute HIV infection that antibody/antigen tests might miss. 1
  • Fourth- or fifth-generation laboratory-based antigen-antibody test must be performed concurrently. 1, 2
  • If HIV RNA testing is unavailable or not feasible, you can still restart PrEP after a rapid point-of-care HIV antibody test while awaiting the laboratory-based antigen/antibody test results, but this is a compromise approach. 1
  • Critical pitfall: Starting PrEP during undiagnosed acute HIV infection can lead to drug resistance, particularly M184V/I mutations. 2

Essential Renal Function Assessment

Since this patient has been off PrEP for 2 years, baseline renal function must be reassessed before restarting:

  • Serum creatinine with calculated creatinine clearance (CrCl) is mandatory. 1, 2
  • TDF-based PrEP is contraindicated if CrCl <60 mL/min. 2, 3
  • Use the Cockcroft-Gault formula for calculation. 1

Hepatitis B Testing

  • Hepatitis B surface antigen (HBsAg) testing is essential because stopping tenofovir-based PrEP in HBV-positive patients can cause severe hepatitis flares, liver decompensation, and liver failure. 2, 3
  • This is particularly important after a 2-year gap, as the patient's HBV status may have changed. 2

Additional Baseline Testing

Before restarting PrEP, also obtain:

  • Hepatitis C antibody testing (if not previously positive or if status unknown). 1, 2
  • STI screening by nucleic acid amplification test (NAAT) for Neisseria gonorrhoeae and Chlamydia trachomatis from all exposure sites (genital, rectal, pharyngeal based on sexual practices). 1, 2
  • Syphilis serology. 1, 2
  • Pregnancy testing for individuals of childbearing potential. 1, 2
  • Hepatitis A IgG antibody for men who have sex with men and people who inject drugs (if not known to be immune). 1, 2

Timing Considerations for Restart

If HIV test results from within the past 7 days are negative, you can initiate PrEP while awaiting further diagnostics and safety assessments. 1 However, given the 2-year hiatus, fresh testing is strongly recommended. 1

Follow-Up Testing After Restart

Once PrEP is restarted, the monitoring schedule resets:

  • At 1 month: Repeat HIV antigen-antibody test to catch any breakthrough infections early. 1, 2
  • Every 3 months (quarterly): HIV antigen-antibody testing, STI screening (gonorrhea, chlamydia, syphilis), and pregnancy testing if applicable. 1, 2
  • Creatinine clearance: At first quarterly visit, then annually (or every 3-6 months if patient has risk factors like age >50, baseline CrCl <90 mL/min, diabetes, or hypertension). 1, 2

Common Pitfalls to Avoid

  • Do not skip HIV RNA testing if available—the 2-year gap represents substantial time for potential HIV exposure, and acute infection must be ruled out definitively. 1
  • Do not restart PrEP with only a rapid antibody test—this misses acute HIV infection and risks creating drug resistance. 1, 2
  • Do not forget hepatitis B testing—abrupt discontinuation of tenofovir in HBV-positive patients can be life-threatening. 2, 3
  • Do not assume prior renal function is still normal—2 years is sufficient time for renal status to change. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Laboratory Testing for PrEP Initiation and Monitoring

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.